MEETINGS - Conference on New Approaches for Compliance after FDA Modernisation Act 1997 (UK) May 1998:
This article was originally published in Clinica
Executive Summary
New Approaches for Compliance after the FDA Modernisation Act 1997 will be the subject of an IBC conference in London on May 18. Issues to be addressed include what effect the reforms will have on the product review system; how the FDA will evaluate exemption requests; changes to labelling and promotion of medical devices; the impact the new law will have on post marketing activities; and possible implications for mutual recognition agreements and global harmonisation. For more information contact IBC in the UK. Tel: +44 171 453 5492. Fax: +44 171 453 2739.